Eli Lilly Levels $500M Attack On Canadian Patent Law

Law360, Los Angeles (September 12, 2013, 11:05 PM EDT) -- Eli Lilly & Co. launched a $500 million assault on Canadian patent law Thursday with a notice of arbitration challenging the Canadian government’s so-called promise doctrine, saying it unfairly discriminates against pharmaceutical companies in violation of a North American Free Trade Agreement rule.

Canada's promise doctrine seeks to identify the utility of an invention when its patent is contested in court, requiring a patent holder being sued to prove that it had demonstrated the utility it promised to deliver in its patent application.

The 2005 law...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.